Warfarin Dosing

Estimate warfarin Coumadin dose adjustment from current INR, target range, and weekly dose using ACCP and ASH evidence-based guidelines. Free online Coumadin INR calculator for clinicians and patients.

Estimate warfarin (Coumadin) dose adjustment based on current INR using ACCP/ASH guidelines

About This Calculator

The Warfarin Dosing Calculator (Coumadin calculator) helps clinicians and patients estimate appropriate warfarin dose adjustments based on the current INR level, target INR range, total weekly warfarin dose, and bleeding status. Warfarin is one of the most widely used oral anticoagulants, prescribed for preventing stroke in atrial fibrillation, treating and preventing deep vein thrombosis (DVT) and pulmonary embolism (PE), and managing patients with mechanical heart valves.

Our calculator follows the evidence-based guidelines from the American College of Chest Physicians (ACCP) 9th edition and the American Society of Hematology (ASH) 2018 guidelines for optimal anticoagulation management. The dose adjustment recommendations are based on the validated INR warfarin dosing chart that accounts for both INR deviation magnitude and target range. The calculator also provides specific bleeding management recommendations for serious and life-threatening bleeding scenarios.

Regional Notes

United States: Warfarin (Coumadin) remains widely prescribed. INR monitoring is typically done at anticoagulation clinics, point-of-care testing, or home INR monitors. Medicare and most insurance plans cover INR testing. The ACCP guidelines are the standard of care.

United Kingdom: Warfarin is commonly used under NHS guidance. NICE guidelines recommend regular INR monitoring with targets matching ACCP standards. DOACs are increasingly used first-line for AF and VTE, but warfarin remains essential for mechanical valves and certain thrombophilic conditions.

India: Warfarin is widely available and affordable compared to DOACs. INR testing is available at most diagnostic labs. Generic warfarin (Acitrom) is commonly prescribed. Patient education about vitamin K-rich foods and drug interactions is especially important in the Indian context given dietary diversity.

Disclaimer: This calculator is for educational and reference purposes only. Always consult a qualified healthcare professional for medical decisions regarding anticoagulation therapy.

Frequently Asked Questions

How accurate is the warfarin dosing calculator?

This calculator uses ACCP (American College of Chest Physicians) 9th edition and ASH (American Society of Hematology) 2018 evidence-based guidelines for warfarin dose adjustment based on INR. Results should always be verified by a healthcare professional and clinical judgment should take precedence over any automated recommendation.

What is the target INR range for warfarin therapy?

The standard target INR range is 2.0-3.0 for most indications including atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), and cardiomyopathy. A higher target of 2.5-3.5 is recommended for patients with mechanical heart valves, particularly in the mitral position. Always follow your prescribing physician's specific target range.

What should I do if my INR is too high?

If INR is above the therapeutic range, management depends on the degree of elevation and presence of bleeding. For INR 3.1-3.9 without bleeding, consider omitting one dose or decreasing the maintenance dose by 5-15% with recheck in 3-7 days. For INR above 4.0 without bleeding, hold warfarin or decrease dose by 5-20% and recheck in 1 day. If serious or life-threatening bleeding occurs, hold warfarin immediately and administer vitamin K and/or PCC/FFP per institutional protocol.

What should I do if my INR is too low?

If INR is below the therapeutic range, consider increasing the maintenance dose by 5-20% depending on how far below range it is. A single booster dose of 1.5-2 times the daily maintenance dose may be considered. Schedule the next INR check in 3-7 days. Always check for missed doses, drug interactions, dietary changes (increased vitamin K intake), and medication non-compliance before adjusting the dose.

How often should INR be monitored on warfarin?

INR monitoring frequency depends on stability. During initial dosing and after dose adjustments, INR is typically checked every 3-7 days. Once therapeutic and stable, the interval can be extended up to every 4 weeks. Factors like new medications, dietary changes, illness, or hospitalization may require more frequent monitoring. Patients on long-term stable therapy may have INR checks every 4-6 weeks in some protocols.

Can I use warfarin instead of DOACs like rivaroxaban or apixaban?

Warfarin is a vitamin K antagonist that requires regular INR monitoring, while DOACs (direct oral anticoagulants) such as rivaroxaban (Xarelto), apixaban (Eliquis), and dabigatran (Pradaxa) do not require routine monitoring. Warfarin is preferred for mechanical heart valves and certain thrombophilic conditions. DOACs are often preferred for atrial fibrillation and VTE treatment due to fixed dosing and fewer food interactions. The choice depends on the indication, renal function, cost, and patient preference.

What factors can affect warfarin metabolism?

Many factors affect warfarin metabolism including diet (vitamin K-rich foods like leafy greens), medications (antibiotics, antifungals, NSAIDs, amiodarone, statins), alcohol consumption, liver function, thyroid status, acute illness with diarrhea or vomiting, genetic factors (CYP2C9 and VKORC1 variants), and age. Any significant changes in these factors require closer INR monitoring and potential dose adjustment.

How do I convert from warfarin to a DOAC?

Converting from warfarin to a DOAC requires careful planning. For apixaban or rivaroxaban: stop warfarin and start the DOAC when INR falls below 2.0-2.5 depending on the specific DOAC. For dabigatran: stop warfarin 1-3 days before and start dabigatran when INR falls below 2.0. For edoxaban: stop warfarin and start when INR is 2.5 or below. Always consult current prescribing information and involve a healthcare professional for anticoagulant transitions.